What we screen for
Conditions where early knowledge changes outcomes.
We focus on conditions where genetic information is genuinely actionable — where knowing early leads to better monitoring, earlier treatment, or more informed care decisions.
Developmental & Neurological
Autism spectrum disorder, intellectual disability, and developmental delay have a genetic cause in up to 40% of cases. A result can end a diagnostic odyssey and unlock targeted therapies.
Epilepsy & Seizure Disorders
Over 30% of childhood epilepsies are genetic in origin. The specific variant often determines which medications work — and which to avoid.
Inherited Cardiac Conditions
Hypertrophic cardiomyopathy, Long QT syndrome, and arrhythmogenic cardiomyopathy can be present at birth with no outward signs. Early identification allows proactive monitoring and prevention.
Metabolic Disorders
Many metabolic conditions are manageable when identified early. Left undetected, they can cause serious, preventable harm during childhood development.
Pharmacogenomics
Your child's genes affect how they process common medications. Variants in genes like CYP2D6 and TPMT can mean standard doses are ineffective or dangerous.
Rare Disease Screening
We screen for hundreds of individually rare but collectively common conditions — many of which now have disease-modifying therapies available when identified early.